Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients

Clinical trial NCT01781702 · COMPLETED

Trial details

NCT number: NCT01781702
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pelubiprofen Celebrex Rheumatoid Arthritis

Start date: 2010-10-01
Primary completion: 2011-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.